Literature DB >> 17350164

PAX3 and PAX3-FKHR promote rhabdomyosarcoma cell survival through downregulation of PTEN.

Hong Gui Li1, Qiuyu Wang, Hong Mei Li, Shant Kumar, Craig Parker, Mark Slevin, Patricia Kumar.   

Abstract

PAX3 or PAX3-FKHR expression is implicated in cell transformation and tumourigenesis. Here, C2C12 myoblasts were transfected with a sense Pax3 vector and a pTet-On system to induce Pax3 expression, whereas to downregulate PAX3-FKHR, Rh18 was transfected with an antisense Pax3 with a pTet-On system. The inhibition of PAX3-FKHR in Rh18 induced upregulation of PTEN. Decreased resistance to apoptosis and increased transformation ability were observed in the Rh18 cells with PAX3-FKHR downregulation. Conversely, Pax3 induction in C2C12 cells downregulated the expression of PTEN and p27(Kip1). These results indicate that the involvement of PAX3 and PAX3-FKHR in rhabdomyosarcoma tumourigenesis may be through downregulation of PTEN tumour suppressor gene, affecting the PTEN/AKT survival pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350164     DOI: 10.1016/j.canlet.2007.01.020

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  Insights into the Role of PAX-3 in the Development of Melanocytes and Melanoma.

Authors:  Jessica Diann Hathaway; Azizul Haque
Journal:  Open Cancer J       Date:  2011-01-01

2.  Zebrafish rhabdomyosarcoma reflects the developmental stage of oncogene expression during myogenesis.

Authors:  Narie Y Storer; Richard M White; Audrey Uong; Emily Price; G Petur Nielsen; David M Langenau; Leonard I Zon
Journal:  Development       Date:  2013-07       Impact factor: 6.868

3.  Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes.

Authors:  Lin Xu; Yanbin Zheng; Jing Liu; Dinesh Rakheja; Sydney Singleterry; Theodore W Laetsch; Jack F Shern; Javed Khan; Timothy J Triche; Douglas S Hawkins; James F Amatruda; Stephen X Skapek
Journal:  Cell Rep       Date:  2018-07-03       Impact factor: 9.423

Review 4.  Uncovering metabolism in rhabdomyosarcoma.

Authors:  Eugenio Monti; Alessandro Fanzani
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

5.  Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.

Authors:  Karen Fernandez; Yelda Serinagaoglu; Sue Hammond; Laura T Martin; Paul T Martin
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

Review 6.  Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.

Authors:  Jennifer D Kubic; Kacey P Young; Rebecca S Plummer; Anton E Ludvik; Deborah Lang
Journal:  Pigment Cell Melanoma Res       Date:  2008-12       Impact factor: 4.693

7.  Rhabdomyosarcomas in aging A/J mice.

Authors:  Roger B Sher; Gregory A Cox; Kevin D Mills; John P Sundberg
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

8.  Analysis of PTEN methylation patterns in soft tissue sarcomas by MassARRAY spectrometry.

Authors:  Liang Yin; Wei-Juan Cai; Chun-Xia Liu; Yun-Zhao Chen; Jian-Ming Hu; Jin-Fang Jiang; Hong-An Li; Xiao-Bin Cui; Xiang-Yun Chang; Wen Jie Zhang; Kan Sun; Feng Li
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

9.  Dissecting the PI3K Signaling Axis in Pediatric Solid Tumors: Novel Targets for Clinical Integration.

Authors:  Amos H P Loh; Rachel C Brennan; Walter H Lang; Robert J Hickey; Linda H Malkas; John A Sandoval
Journal:  Front Oncol       Date:  2013-04-23       Impact factor: 6.244

Review 10.  Pax genes in embryogenesis and oncogenesis.

Authors:  Qiuyu Wang; Wen-Hui Fang; Jerzy Krupinski; Shant Kumar; Mark Slevin; Patricia Kumar
Journal:  J Cell Mol Med       Date:  2008-07-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.